EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The effect of 5% and 10% povidone-iodine antiseptic concentrations on postoperative sensorineural hearing loss in tympanoplasty: a triple-blind randomized clinical trial

Mohammad Faramarzi, Ali Faramarzi, Sareh Roosta, Mahmoud Shishegar, Mohammadreza Khademalizadeh, Sara S Nabavizadeh, Amir Keyvan Sazgar

European Archives of Oto-Rhino-Laryngology · 2025

DOI: 10.1007/s00405-025-09310-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von Mohammad Faramarzi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology Research Center, Department of Otolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Povidone-Iodine, Anti-Infective Agents, Local, Hearing Loss, Sensorineural, Tympanoplasty. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the ototoxicity of povidone iodine (PVP-I) at concentrations of 5% and 10% during tympanoplasty by assessing frequency-specific audiometric outcomes and graft success rates in a large cohort of patients. METHODS: This prospective, triple-blinded, randomized clinical trial enrolled 542 patients undergoing primary tympanoplasty. After excluding patients for inadequate follow-up, 204 ears received 10% PVP-I and 199 ears received 5% PVP-I. Audiometric evaluations, including bone conduction (BC), air conduction (AC), air-bone gap (ABG), and speech reception threshold (SRT), were conducted preoperatively and 12 months postoperatively. The primary outcome was the incidence of sensorineural hearing loss (SNHL), defined as an increase in BC threshold of more than 10 dB. Secondary outcomes included graft success rate and audiometric gains. RESULTS: The overall incidence of SNHL was 1.5% in the 10% PVP-I group and 1.0% in the 5% PVP-I group, with no significant difference (P = 1.000). In ears with preoperative mixed hearing loss, SNHL at 0.25 kHz was significantly higher in the 10% PVP-I group (28.9%) compared to the 5% PVP-I group (6.7%) (P = 0.002). Graft success rates were 94.1% and 97.0% in the 10% and 5% PVP-I groups, respectively (P = 0.164). No clinically significant differences in audiometric gains were observed between the groups. CONCLUSION: Both 5% and 10% PVP-I concentrations are safe for antiseptic preparation in tympanoplasty, as evidenced by low rates of SNHL and high graft success rates. These findings support the use of PVP-I in human otologic surgery without significant ototoxic risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Povidone-IodineAnti-Infective Agents, LocalHearing Loss, SensorineuralTympanoplastyPostoperative ComplicationsHumansFemaleMaleAdultMiddle AgedProspective StudiesAudiometryYoung AdultAgedBone ConductionAdolescentTreatment OutcomeDouble-Blind Method

Stichwörter der Autor:innen

Hearing lossOtotoxicityPovidone-iodineSensorineuralTympanoplasty

Substanzen

Povidone-IodineAnti-Infective Agents, Local

Autor:innen und Institutionen

  • Otolaryngology Research Center, Department of Otolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.
  • Women and Kids Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Otolaryngology Research Center, Department of Otolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran. dr.shishegar@gmail.com.
  • Otolaryngology Research Center, Department of Otolaryngology-Head and Neck Surgery, Tehran University of Medical Sciences, Imam Khomeini Medical Complex, Tehran, Iran.

Zitieren

APA

Faramarzi, M., Faramarzi, A., Roosta, S., Shishegar, M., Khademalizadeh, M., Nabavizadeh, S. S., & Sazgar, A. K. (2025). The effect of 5% and 10% povidone-iodine antiseptic concentrations on postoperative sensorineural hearing loss in tympanoplasty: a triple-blind randomized clinical trial. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-025-09310-2

Vancouver

Faramarzi M, Faramarzi A, Roosta S, Shishegar M, Khademalizadeh M, Nabavizadeh SS, et al. The effect of 5% and 10% povidone-iodine antiseptic concentrations on postoperative sensorineural hearing loss in tympanoplasty: a triple-blind randomized clinical trial. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-025-09310-2

BibTeX
@article{Faramarzi2025,
  author = {Faramarzi, Mohammad and Faramarzi, Ali and Roosta, Sareh and Shishegar, Mahmoud and Khademalizadeh, Mohammadreza and Nabavizadeh, Sara S and Sazgar, Amir Keyvan},
  title = {The effect of 5% and 10% povidone-iodine antiseptic concentrations on postoperative sensorineural hearing loss in tympanoplasty: a triple-blind randomized clinical trial},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2025},
  doi = {10.1007/s00405-025-09310-2}
}
Kostenlos starten →